↓ Skip to main content

Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Overview of attention for article published in Nature Medicine, June 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

news
10 news outlets
blogs
1 blog
twitter
54 X users
facebook
1 Facebook page

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
108 Mendeley